by Sam | 23 Apr 2014 | Uncategorized
Campaigners are calling on pharmaceutical company Roche to cut the price of a pioneering new breast cancer treatment amid indications the NHS drugs watchdog is set to reject its use on the service on cost grounds. NICE said the £90,000 cost of trastuzumab emtansine is...
by Chris Rogers | 12 Feb 2014 | Uncategorized
The National Institute for Health and Care Excellence (NICE) has confirmed that millions more people should be prescribed cholesterol-lowering statins to protect them against heart attacks and strokes. Cardiovascular disease accounts for around 180,000 deaths per year...
by Chris Rogers | 28 Jan 2014 | Uncategorized
It’s been claimed that thousands of men with advanced prostate cancer could be denied a new drug following guidance from NICE. NICE initially recommended for NHS funding last October but have reversed this decision. NICE have justified the decision claiming there is a...
